Back
Globus Medical 10K Form
Buy
70
GMED
Globus Medical
Last Price:
84.70
Seasonality Move:
8.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-07 | 10Q | GMED/Globus Medical Quarterly |
| 2023-11-07 | 10Q | GMED/Globus Medical Quarterly |
| 2023-08-03 | 10Q | GMED/Globus Medical Quarterly |
| 2023-05-04 | 10Q | GMED/Globus Medical Quarterly |
| 2022-11-08 | 10Q | GMED/Globus Medical Quarterly |
| 2022-08-04 | 10Q | GMED/Globus Medical Quarterly |
Receive GMED News And Ratings
See the #1 stock for the next 7 days that we like better than GMED
GMED Financial Statistics
Sales & Book Value
| Annual Sales: | $1.57B |
|---|---|
| Cash Flow: | $161.7M |
| Price / Cash Flow: | 39.54 |
| Annual Sales: | $29.94 |
| Price / Book: | 2.83 |
Profitability
| EPS (TTM): | 0.67000 |
|---|---|
| Net Income (TTM): | $91.51M |
| Gross Margin: | $1.02B |
| Return on Equity: | 2.27% |
| Return on Assets: | 1.8% |
Globus Medical Earnings Forecast
Key Globus Medical Financial Ratios
- The Gross Profit Margin over the past 15 years for GMED is 65.05%.
- The Selling, General & Administrative Expenses for GMED have been equal to 41.02% of Gross Profit Margin.
- The Research & Development expenses have been 7.91% of Revenue.
- The Interest Expense is -11.22% of Operating Income.
- The Net Earning history of GMED is 7.83% of Total Revenues.
- Per Share Earnings over the last 15 years have been positive in 8 years.
Globus Medical Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | GMED |
| CUSIP: | 379577 |
| Website: | globusmedical.com |
Debt
| Debt-to-Equity Ratio: | 0.11 |
|---|---|
| Current Ratio: | 2.51 |
| Quick Ratio: | 1.57 |
Price-to-Earnings
| Trailing P/E Ratio: | 79.18 |
|---|---|
| Forward P/E Ratio: | 24.74 |
GMED Technical Analysis vs Fundamental Analysis
Buy
70
Globus Medical (GMED)
is a Buy
Is Globus Medical a Buy or a Sell?
-
Globus Medical stock is rated a Buy
The current Globus Medical [GMED] share price is $84.72. The Score for GMED is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.